首页> 外文期刊>Advances in Nephrology >Chronic Kidney Disease: Evolution of Healthcare Costs and Resource Consumption from Predialysis to Dialysis in Piedmont Region, Italy
【24h】

Chronic Kidney Disease: Evolution of Healthcare Costs and Resource Consumption from Predialysis to Dialysis in Piedmont Region, Italy

机译:慢性肾脏病:意大利皮埃蒙特地区从透析前到透析的医疗保健费用和资源消耗的演变

获取原文
       

摘要

This study aims at assessing the evolution in healthcare costs for chronic kidney disease (CKD) patients through the analysis of administrative databases of Piedmont region, Italy. This is a retrospective, observational study, for which patients undergoing at least one dialysis for CKD in the period of June 1, 2010–May 31, 2011 were selected. Two subpopulations were evaluated: patients incident-to-dialysis observed for the 12 months preceding dialysis entrance (PreD) and “established” dialysis patients (at least 120 dialyses/year) observed for 12 months (EstD). Overall, 1,059 PreD and 2,018 EstD patients were selected. The average yearly cost per PreD patient accounted for 11,123€ ± 15,095€ (75% hospitalizations, 17% drugs, and 8% diagnostic/therapeutic procedures). The average yearly cost per EstD patient accounted for 53,764€ ± 14,685€ (59% dialysis, 21% diagnostic/therapeutic procedures, 13% hospitalizations, and 6.7% drugs). Among EstD population, hemodialysis patients cost 56,049€ ± 13,473€ per year, whereas peritoneal dialysis patients cost 34,978€ ± 10,847€ per year. The significant difference in expenditure between predialysis and dialysis suggests that prevention, early diagnosis, and the consequent possible delay of dialysis entrance could lead to important savings for healthcare services, as well as a better global health status for patients.
机译:本研究旨在通过对意大利皮埃蒙特地区的行政数据库进行分析,评估慢性肾脏病(CKD)患者的医疗保健费用的变化。这是一项回顾性观察性研究,选择了在2010年6月1日至2011年5月31日期间接受至少一次CKD透析的患者。对两个亚群进行了评估:在透析入口(PreD)前12个月观察到透析事件的患者和在12个月(EstD)中观察到的“既定”透析患者(每年至少120个透析液)。总体上,选择了1,059名PreD和2,018名EstD患者。每位PreD患者的年均费用为11,123欧元±15,095欧元(75%的住院费,17%的药物和8%的诊断/治疗程序)。每位EstD患者的年平均费用为53,764€±14,685€(透析率为59%,诊断/治疗程序为21%,住院率为13%,药物为6.7%)。在EstD人群中,血液透析患者每年花费56,049€±13,473€,而腹膜透析患者每年花费34,978€±10,847€。透析前和透析之间支出的显着差异表明,预防,早期诊断以及随之而来的透析进入可能的延迟可能会导致医疗服务节省大量费用,并改善患者的全球健康状况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号